SOMERSET, N.J., June 11, 2014 – The Catalent Applied Drug Delivery Institute and American Association of Pharmaceutical Scientists (AAPS), today announced the winners of their “Global Academic Competition for Life Science Leaders of Tomorrow.” Chosen from leading U.S. and International universities with graduate programs in pharmaceutical science, the five winners were:

  • Maren Preis, University of Dusseldorf, Regulatory Challenges & Available Dosage Forms”;
  • Prachi Shah,  St. Johns University, Double Emulsions: Scope and Attempts”;
  • Nilesh Gupta, Texas Tech University, “Challenges in Developing Inhalation Technology: Right Particle Size and Device Selection”;
  • Tannaz Ramezanli, Rutgers University, “Stem Cells as Novel Carriers for Cancer Therapy”;
  • Emrah Ilker Ozay, UMass Amherst, “Slipping through the blood brain barrier with cell penetrating peptide mimics

Each will receive a cash prize of $2,000 and annual membership to the AAPS.

The annual competition aims to identify emerging scientific talent, foster drug delivery education and reward academic excellence and competition entries consisted of original review articles addressing topics such as drug development, delivery technologies, improving therapeutic profiles and bioavailability, pre-formulation, and pediatric drugs. The academic competition reflects the Institute’s commitment to fostering education, collaboration and adoption of drug delivery technologies to develop better treatments for patients.

“The Catalent Institute looks forward to sharing the winning review articles submitted by the five winners from this year’s global academic competition,” said Terry Robinson, Executive Director of the Catalent Applied Drug Delivery Institute. “Expanding the drug delivery toolbox of pharmaceutical scientists to inspire the adoption and innovation of drug delivery technologies is a primary focus of our institute. These articles and other resources can be found on our website:”

“We congratulate the winners on this prestigious award, which recognizes ground-breaking approaches to drug development and pharmaceutical research,” said John Lisack, Jr., CAE, AAPS Executive Director. “AAPS is proud to partner with the Catalent Institute on this program, which offers students a valuable opportunity to compete with some of the world’s foremost scientific talent at the graduate level.”


About Catalent Applied Drug Delivery Institute

Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments and foster industry collaboration on major issues pertaining to drug development, formulation and delivery. It pursues a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of emerging technologies.

About Catalent

 Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in Fiscal 2013 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit


More products. Better treatments. Reliably supplied.™